Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age

BackgroundAlthough heart failure (HF) and supraventricular tachycardias (SVT) are associated with high morbidity and mortality in pediatrics, especially, in children under 6 months; the efficacy of available treatments is limited, requiring the use of off-label therapies. The aim of the study is to...

Celý popis

Podrobná bibliografie

Hlavní autoři:	L. Gómez-Ganda, C. J. Parramón-Teixidó, G. Giralt-García, C. Fernández-García, Q. Ferrer-Menduiña, M. J. Cabañas-Poy
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-02-01
Edice:	Frontiers in Pharmacology
Témata:	heart failure ivabradine pediatrics tachycardia atrial tachycardia ectopic atrial tachycardia
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1502375/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!